文献速递类风湿关节炎

老年起病与年轻起病类风湿关节炎患者的表型与治疗比较

Phenotype and treatment of elderly onset compared with younger onset rheumatoid arthritis patients in international daily practice.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

基于METEOR国际注册数据库7912例RA患者,按起病年龄分为<45岁、45-65岁、>65岁三组,比较基线特征、初始治疗及治疗反应。>65岁组男性更多、血清阴性RA更多且炎症指标略高,初始治疗选择仅略有差异;换药时间及DAS、HAQ改善在各年龄组间无临床相关差异。

要点

  • 老年起病RA(>65岁)男性更多、血清阴性更多、炎症指标略高。
  • 各年龄组初始治疗选择仅略有差异,首次换药时间相似。
  • DAS与HAQ改善随年龄组不同而有统计学交互,但差异无临床意义。

核心结论

  • 老年起病RA患者表型与年轻起病者不同,但换药时机及DAS、HAQ治疗反应无临床相关差异。

研究设计与样本

  • 使用全球METEOR注册数据库的日常实践数据,纳入7912例RA患者。
  • 按诊断时年龄分层为<45岁、45-65岁、>65岁三组。
  • 初始治疗组间比较;Cox回归分析年龄组对首次换药时间的影响;线性混合模型在校正潜在混杂后评估DAS与HAQ反应差异。

主要发现

  • <45岁与45-65岁组相比>65岁组,DAS每月差异分别为-0.02与-0.05分。
  • <45岁与45-65岁组相比>65岁组,HAQ每月差异分别为-0.01与0.02分。
  • 上述差异被认为无临床相关性。

临床怎么用

  • 老年起病RA的初始治疗与换药决策可参照与年轻患者相似的策略,无需因年龄而显著改变治疗反应预期。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify possible differences in baseline characteristics, initial treatment and treatment response between RA patient subgroups based on age at disease onset. METHODS: Daily practice data from the worldwide METEOR registry were used. Patients (7912) were stratified into three age-groups (age at disease diagnosis <45 years, 45-65 years, >65 years). Initial treatment was compared between the different age-groups. With Cox regression analyses the effect of age-group on time-to-switch from first to second treatment was investigated, and with linear mixed models differences in response to treatment (DAS and HAQ) between the age-groups were assessed, after correction for potential confounders. RESULTS: The >65 years age-group included more men, and more seronegative RA with somewhat higher inflammatory markers. Initial treatment choices differed only slightly between the age-groups, and the time-to-switch from initial treatment to the next was similar. DAS and HAQ improvement were dependent on the age-group, reflected by a significant interaction between age-group and outcome. The stratified analysis showed a difference of -0.02 and -0.05 DAS points and, -0.01 and 0.02 HAQ points per month in the <45 and 45-65 years age-groups as compared with the >65 year age group, a difference that did not seem clinically relevant. CONCLUSION: In this international study on worldwide clinical practice, patients with RA onset >65 years include more men and seronegative arthritis, and were initially treated slightly differently than younger patients. We observed no clinically relevant differences in timing of a next treatment step, or response to treatment measured by DAS and HAQ.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Maassen JM, Bergstra SA, Chopra A, et al. Phenotype and treatment of elderly onset compared with younger onset rheumatoid arthritis patients in international daily practice. Rheumatology (Oxford). 2021. PMID: 33537769. doi:10.1093/rheumatology/keab102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。